2021-014 Yan'an Pharmaceutical: Announcement of Appointment of Senior Management
1. The basic situation of appointment and dismissal
(1) The basic situation of appointment and dismissal
In accordance with the relevant provisions of the "Company Law" and the company's articles of association, the 13th meeting of the second board of directors of the company reviewed and approved on April 19, 2021:
Mr. Zhang Wei was appointed as the secretary of the company's board of directors for a term of three years, effective from April 19, 2021. The above-mentioned appointed personnel hold 0 shares of the company, accounting for 0% of the company's share capital, and are not targets of joint punishment for dishonesty.
All directors were notified by email 10 days before the meeting. There were actually 7 directors present. The meeting was presided over by Chairman Wang Xueliang.
This appointment and removal does not need to be submitted to the shareholders meeting for deliberation.
Does this appointment and dismissal involve the change of the secretary of the board of directors:
(2) Reasons for appointment/removal
Due to the resignation of the company’s former secretary of the board of directors, Mr. Su Hongming, the chairman of the board of directors Wang Xueliang proposed that Mr. Zhang Wei take over as the secretary of the board of directors.
(3) Resume of newly appointed directors, supervisors and senior officers
The resume of Mr. Zhang Wei is as follows: male, Chinese nationality, no right of abode abroad, born in 1978, master degree. Graduated from East China Normal University with a master's degree in business management in July 2004; worked as a clerk in the Finance Department of Tunnel Co., Ltd. from August 2004 to May 2007; worked as a business director in the Investment Banking Department of Huatai United Securities from September 2007 to March 2014 ; From May 2016 to June 2018, he served as the CFO of Youjiabao; from January 2019 to June 2020, he served as the financial director and secretary of the board of directors of Tonghe Technology; from July 2020 to April 2021, he was in Shanghai Yuanshi Smart Technology Co., Ltd. is the chief financial officer.
2. The impact of appointment and dismissal on the company
(1) This dismissal/appointment did not cause the number of members of the company's board of directors to fall below the statutory minimum, and did not cause the number of members of the company's board of supervisors to fall below the statutory minimum.
(2) The impact of appointment and dismissal on the company's production and operation:
The appointment of Mr. Zhang Wei as the secretary of the board of directors will help the company to carry out information disclosure work and will not have a significant impact on the company's daily operating activities.
3. Documents for reference
Resolutions of the thirteenth meeting of the second board of directors of Shanghai Yanan Pharmaceutical Yangpu Co., Ltd.
Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
April 20, 2021